Now showing items 1-5 of 5
THE PROGNOSTIC RELATIONSHIP BETWEEN HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES OF HEPATOCELLULAR CARCINOMA, INTRAHEPATIC CHOLANGIOCARCINOMA AND MIXED TYPE
(Vesalius Univ Medical Publ, 2020)
Hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and combined hepatocellular and cholangiocarcinoma are the most common cancers of the liver. in this study, our first aim is to evaluate the relationship between ...
Can hypothyroidism be a protective factor for hepatocellular carcinoma in cirrhosis?
(Lippincott Williams & Wilkins, 2020)
Despite many studies, the molecular mechanisms of hepatocellular carcinoma (HCC) development remain unclear. Thyroid hormone (TH) levels may vary in many chronic diseases including cirrhosis. the aim of this study was to ...
Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis
Introduction: Combined hepatocellular-cholangiocarcinoma is rare and comprises features of hepatocellular carcinoma and cholangiocarcinoma. The treatment of choice has not yet been defined. The aim of the study was to ...
Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria
Aims Hepatocellular adenoma (HCA) is an uncommon liver neoplasm, and studies of HCA subtypes have been primarily limited to France, the USA, and Japan. The aim of this study was to describe the clinicopathological features ...
Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
(SAGE Publications Ltd, 2021)
Introduction: Liver transplantation offers the most reasonable expectation for curative treatment for hepatocellular carcinoma. Living-donor liver transplantation represents a treatment option, even in patients with extended ...